Type
Buy
Instrument
SPARC
Entry Price
₹195.45
Price@Trade
₹195.45
Target Price
₹205
Stop Price
₹190
Valid Till
Feb 11, 2020 3:20 AM
Margin
₹195.45 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹190
Net P&L
-2.79% Loss
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
SPARC Share Price Discussion
Sun Pharma Advanced Research Company Ltd.
NSE: SPARC | BSE: 532872 | ISIN: INE232I01014 | Sector: Miscellaneous
SPARC Rating
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)
SPARC Share Price *
154.65 -4.7 (-2.95%)
* (quote may be delayed)
Find answers to all your questions on live SPARC message board: Is SPARC buy or sell? Should I buy SPARC shares? Why are SPARC shares falling? Should I invest in SPARC stock?
You can also check SPARC share price target recommended by brokerages.
SPARC Discussion Forum
@newsbot • Reputation: 2,324
USFDA rejects SPARC's cancer drug application
SPARC is reviewing the CRL and intends to work with the USFDA as soon as possible to address the concerns raised, it added.
SPARC is reviewing the CRL and intends to work with the USFDA as soon as possible to address the concerns raised, it added.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,324
Nifty may scale up towards all-time high of 12,400 in Feb series: Axis Securities
We expect Smallcap and midcap stocks to perform further and we can see another 3-5% upside in Midcap and smallcap space.
We expect Smallcap and midcap stocks to perform further and we can see another 3-5% upside in Midcap and smallcap space.
Moneycontrol
Like
reply
Reply
@thekingofequity • Reputation: 792
Sparc
Cmp @ 205 spot
Strong Resistance @ 220
If break and sustain/close above it will see sharp up move for tgt 235-250-270++ mark in days to come
Or best buy on dip @ 175
SL @ Your own risk
1
reply
Reply
@konartradetalk • Reputation: 28,744
💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
BUY SPARC AT THE VERY BEGINING
STRICT STOP LOSS - 181
1ST TARGET - 184.80
2ND TARGET - 185.75
3RD TARGET - 187
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please cons...
Read more...
Like
reply
Reply
@Freetips • Reputation: 543
DELIVERY BUY SPARC CMP 166.55 TGT 177.50 SL 159
Like
reply
Reply (2)
Latest replies
BOOK 50% PROFIT CMP 173.80 AND TRAIL SL AT 168 (DELIVERY BUY SPARC CMP 166.5 TGT 177.50 SL 159)
TARGET ACHEIVED (DELIVERY BUY SPARC CMP 166.5 TGT 177.50 SL 159)
@konartradetalk • Reputation: 28,744
💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
BUY SPARC AT THE VERY BEGINING
STRICT STOP LOSS - 161
TARGET - 164/166/168
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your financial adviser befo...
Read more...
Like
reply
Reply
@ravikanthchopperla • Reputation: 12,174
09-Dec-2019 11:05:29 AM - SUN PHARMA ADVANCED RESEARCH - ABRAXIS BIOSCIENCES DISMISSED PATENT INFRINGEMENT COMPLAINT FILED AGAINST SPARC ON SPARC'S NDA FOR PICS
09-Dec-2019 11:05:44 AM - SUN PHARMA ADVANCED RESEARCH COMPANY LTD SAYS SPARC WILL ALSO INFORM THE USFDA OF THE DISMISS...
Read more...
Like
reply
Reply
@ENRITCHansraj • Reputation: -159,706
#Hansraj pandey in SPARCBUY SPARC CASH 172-170 STOP LOSS 169 TARGET ...
Sl hit
Like
reply
Reply
@mohammedhossain • Reputation: 2,569
BUY SPARC CASH 172-170 STOP LOSS 169 TARGET 175/177
Like
reply
Reply
@ENRITCHansraj • Reputation: -159,706
#Hansraj pandey in SPARCBUY SPARC CASH 167 STOP LOSS 164 TARGET 169/172
FINAL TGT DONE🎯🎯 BOOK HUGE PROFIT 🎯🎯🎯💪
Like
reply
Reply
@mohammedhossain • Reputation: 2,569
BUY SPARC CASH 167 STOP LOSS 164 TARGET 169/172 #sparc
Like
reply
Reply
@konartradetalk • Reputation: 28,744
💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
BUY SPARC AT THE VERY BEGINING
STRICT STOP LOSS - 154.75
TARGET - 162/164/166
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your financial adviser before any Trade. All Equity a...
Read more...
Like
reply
Reply
@mohammedhossain • Reputation: 2,569
Intraday Cash Buy SPARC @156.80-157.8 SL 152.7 TGT 167 #SPARC
Like
reply
Reply
@RUDRA007 • Reputation: 2,558
RUDRA ANSH OF SHIV in SPARCINVESTMENT IDEA :- BUY SPARC ABOVE 146,, STOPLO...
SPARC MADE 165 AFTER INVESTMENT CALL,,
Like
reply
Reply
@mohammedhossain • Reputation: 2,569
Intraday Cash Buy SPARC @157.30-158.1 SL 153.5 TGT 166 #SPARC
Like
reply
Reply
@ravikanthchopperla • Reputation: 12,174
BRIEF-India's Sun Pharma Advanced Research Company Sept Quarter Loss Widens - Reuters
04-Nov-2019 02:11:51 PM
Nov 4 (Reuters) - Sun Pharma Advanced Research Company Ltd SPRC.NS:
SEPT QUARTER LOSS 631.6 MILLION RUPEES VERSUS 25.8 MILLION RUPEES YEAR AGO
SEPT QUARTER REVENUE FROM O...
Read more...
1
reply
Reply
@RUDRA007 • Reputation: 2,558
RUDRA ANSH OF SHIV in SPARCINVESTMENT IDEA :- BUY SPARC ABOVE 146,, STOPLO...
SPARC AROUND 146,, ONCE IT SUSTAINS FOR 15 TO 20 MINS BUY THIS ROCKET,,,,
1
reply
Reply
@RUDRA007 • Reputation: 2,558
INVESTMENT IDEA :- BUY SPARC ABOVE 146,, STOPLOSS OF 127,, TARGETS OF 176,,188,,201,,217
Like
reply
Reply
@newsbot • Reputation: 2,324
SPARC gets orphan drug designation for Phenobarbital but shares decline 5%
The Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital, which is used in treating neonatal seizures.
The Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital, which is used in treating neonatal seizures.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,324
Stocks in the news: Glenmark Pharma, Ashok Leyland, Lupin, VST Tillers, BEML, SPARC
Apar Industries | Ashok Leyland | Prakash Industries | Eveready Industries and JSW Steel are stocks, which are in news today.
Apar Industries | Ashok Leyland | Prakash Industries | Eveready Industries and JSW Steel are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
SPARC...166
🅱️UY®️ANGE...165 TO 155
PUT 150 AS 🆑️STPLS
EXPECT 🔜 180/190
Like
reply
Reply
@KINGofEQUITY • Reputation: 0
Sparc
For NSE CASH traders good to accumulate on every dip with support 146. For further upmove till 165 or 170 mark in days to come
Like
reply
Reply
@thekingofequity • Reputation: 792
Sparc
For NSE CASH traders good to accumulate on every dip with support 146. For further upmove till 165 or 170 mark in days to come
Like
reply
Reply
@konartradetalk • Reputation: 28,744
YOUR FREE GIFT CASH CALL FOR TODAY!!
BUY SPARC AT THE VERY BEGINING
STRICT STOP LOSS - 139
TARGET - 142/143/145
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your financial adviser before any Trade. All Equity and FNO Trades are su...
Read more...
Like
reply
Reply
@newsbot • Reputation: 2,324
An evening walk down D-St: Sensex, Nifty fall for 2nd day in a row; Yes Bank, Tata Motors crash
Broader Midcap and Smallcap indices underperformed Sensex, falling 1.32 percent and 1.43 percent, respectively.
Broader Midcap and Smallcap indices underperformed Sensex, falling 1.32 percent and 1.43 percent, respectively.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,324
Sun Pharma Advanced slips 3% after US firm alleges infringement of patent
The company believes that this lawsuit is without merit and will vigorously defend against these allegations.
The company believes that this lawsuit is without merit and will vigorously defend against these allegations.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,324
Stocks in the news: SPARC, SpiceJet, Alembic Pharma, Dr Reddys Labs, United Spirits, Deepak Nitrite
Alembic Pharma | Dr Reddy's Labs | United Spirits | HDIL | Deepak Nitrite | IOL Chemicals and Freshtrop Fruits are stocks which are in the news today.
Alembic Pharma | Dr Reddy's Labs | United Spirits | HDIL | Deepak Nitrite | IOL Chemicals and Freshtrop Fruits are stocks which are in the news today.
Moneycontrol
Like
reply
Reply
@TTA • Reputation: 9,675
Sparc - Abraxis Biosciences has filed a complaint in the U.S. Court which alleges that the Spark's filing of new drug application for Taclantis injection as an act of infringement of the Orange Book listed patents for Abraxane. Sentimentally Negative
Like
reply
Reply
@newsbot • Reputation: 2,324
Sun Pharma Adv Standalone June 2019 Net Sales at Rs 17.32 crore, up 3.03% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,324
Podcast | Stock picks of the day: 200-DMA likely to act as tough support for Nifty
The long-term 200-DMA levels of 11,130 is going to act as a crucial support area for the Nifty. On the upside, resistance is seen around the 11,400 zone.
The long-term 200-DMA levels of 11,130 is going to act as a crucial support area for the Nifty. On the upside, resistance is seen around the 11,400 zone.
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,324
A morning walk down Dalal Street | Bounce back can’t be ruled out as Nifty looks oversold
The index appears to be getting more pronounced as Nifty closed for the second session below its 200-day exponential moving average (11,296), suggest experts.
The index appears to be getting more pronounced as Nifty closed for the second session below its 200-day exponential moving average (11,296), suggest experts.
www.moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,324
Nifty dives below long-term moving average, joins over 300 Nifty500 stocks
Like
reply
Reply
- NewsBotFeb 11 2:48 AMUSFDA rejects SPARC's cancer drug applicationMoneycontrolNewsBotFeb 10 5:48 AMNifty may scale up towards all-time high of 12,400 in Feb series: Axis SecuritiesMoneycontrolNewsBotOct 7 8:28 AMSPARC gets orphan drug designation for Phenobarbital but shares decline 5%MoneycontrolNewsBotOct 7 1:13 AMStocks in the news: Glenmark Pharma, Ashok Leyland, Lupin, VST Tillers, BEML, SPARCMoneycontrolNewsBotAug 21 10:38 AMAn evening walk down D-St: Sensex, Nifty fall for 2nd day in a row; Yes Bank, Tata Motors crashMoneycontrolNewsBotAug 21 3:29 AMSun Pharma Advanced slips 3% after US firm alleges infringement of patentMoneycontrolNewsBotAug 21 3:29 AMStocks in the news: SPARC, SpiceJet, Alembic Pharma, Dr Reddys Labs, United Spirits, Deepak NitriteMoneycontrolNewsBotJul 29 10:33 AMSun Pharma Adv Standalone June 2019 Net Sales at Rs 17.32 crore, up 3.03% Y-o-Ymoneycontrol.comNewsBotJul 26 1:58 AMPodcast | Stock picks of the day: 200-DMA likely to act as tough support for Niftymoneycontrol.comNewsBotJul 26 12:53 PMA morning walk down Dalal Street | Bounce back can’t be ruled out as Nifty looks oversoldwww.moneycontrol.com
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.